Key Insights

Highlights

Success Rate

79% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

10.7%

6 terminated out of 56 trials

Success Rate

79.3%

-7.2% vs benchmark

Late-Stage Pipeline

13%

7 trials in Phase 3/4

Results Transparency

17%

4 of 23 completed with results

Key Signals

4 with results79% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (23)
Early P 1 (1)
P 1 (1)
P 2 (3)
P 3 (3)
P 4 (4)

Trial Status

Completed23
Unknown17
Terminated6
Recruiting4
Enrolling By Invitation2
Not Yet Recruiting2

Trial Success Rate

79.3%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (56)

Showing 20 of 20 trials
NCT07173127Not ApplicableRecruitingPrimary

The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters

NCT06153667RecruitingPrimary

Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)

NCT06474065CompletedPrimary

Pregnancy Outcomes Following Myomectomy

NCT05416424Not ApplicableActive Not RecruitingPrimary

Life Study: Lifestyle Intervention in Fibroid Elimination

NCT07269535Not Yet RecruitingPrimary

A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma

NCT04272216CompletedPrimary

An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres

NCT07129005Enrolling By InvitationPrimary

Radiomics-Based Non-Invasive MRI Differentiation of Uterine Sarcomas and Fibroids

NCT06430320Enrolling By InvitationPrimary

Ascertaining Longterm Outcomes of Fibroid Treatments

NCT05386615RecruitingPrimary

Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

NCT06106633Not ApplicableTerminated

Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization

NCT06705075Phase 2RecruitingPrimary

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

NCT03118037TerminatedPrimary

Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry

NCT03412890Phase 3Completed

LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT06244251Not ApplicableActive Not RecruitingPrimary

Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids

NCT06234670UnknownPrimary

Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids

NCT03211481CompletedPrimary

Design of an Intra-operative Blood Conservation Pathway at Open Myomectomy

NCT04345003Not ApplicableCompletedPrimary

MR Elastography Parameters Impact on MR-HIFU Efficacy in Uterine Fibroids

NCT05986266Phase 1CompletedPrimary

Evaluating Efficacy of Intravenous Carbetocin Versus Intramyometrial Injection of Adrenaline in Reducing Blood Loss

NCT06020924Unknown

The Effects of Uterine Fibroids on Pregnancy in Women

NCT06009562UnknownPrimary

Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study

Scroll to load more

Research Network

Activity Timeline